Sotabase
Home
Researchers
Career
·
Research Scientist
,
UC Berkeley Berkeley Artificial Intelligence Research Lab (BAIR)
2019–
·
PhD in Computer Science
,
UC Berkeley
2015–2019
·
Researcher (PhD)
,
UC Berkeley
2015–2019
Publications
(64)
Immune evasion via PD-1/PD-L1 on NK cells and monocyte/macrophages is more prominent in Hodgkin lymphoma than DLBCL.
Blood · 2018
270
cited
Progression of Disease Within 24 Months in Follicular Lymphoma Is Associated With Reduced Intratumoral Immune Infiltration
Journal of Clinical Oncology · 2019
99
cited
LAG3: a novel immune checkpoint expressed by multiple lymphocyte subsets in diffuse large B-cell lymphoma.
Blood Advances · 2020
87
cited
Ratios of T-cell immune effectors and checkpoint molecules as prognostic biomarkers in diffuse large B-cell lymphoma: a population-based study.
The Lancet Haematology · 2015
84
cited
EBV-tissue positive primary CNS lymphoma occurring after immunosuppression is a distinct immunobiological entity.
Blood · 2020
69
cited
Cathepsin S Alterations Induce a Tumor-Promoting Immune Microenvironment in Follicular Lymphoma.
Cell Reports · 2020
68
cited
The T-cell Receptor Repertoire Influences the Tumor Microenvironment and Is Associated with Survival in Aggressive B-cell Lymphoma
Clinical Cancer Research · 2016
67
cited
Subtype-specific and co-occurring genetic alterations in B-cell non-Hodgkin lymphoma
bioRxiv · 2019
56
cited
The tumour microenvironment is immuno‐tolerogenic and a principal determinant of patient outcome in EBV‐positive diffuse large B‐cell lymphoma
European Journal of Haematology · 2019
47
cited
A high LDH to absolute lymphocyte count ratio in patients with DLBCL predicts for a poor intratumoral immune response and inferior survival
OncoTarget · 2018
28
cited
Outcomes of stage I/II follicular lymphoma in the PET era: an international study from the Australian Lymphoma Alliance.
Blood Advances · 2019
21
cited
PD-1 and LAG-3 Checkpoint Blockade: Potential Avenues for Therapy in B-Cell Lymphoma
Cells · 2021
21
cited
Epstein–Barr virus‐associated lymphomas decoded
British Journal of Haematology · 2023
20
cited
Successful treatment of Epstein–Barr virus–associated primary central nervous system lymphoma due to post‐transplantation lymphoproliferative disorder, with ibrutinib and third‐party Epstein–Barr virus–specific T cells
American Journal of Transplantation · 2021
16
cited
Intratumoral T cells have a differential impact on FDG-PET parameters in follicular lymphoma.
Blood Advances · 2021
13
cited
Efficacy of Immune Checkpoint Inhibitors for the Treatment of Advanced Melanoma in Patients with Concomitant Chronic Lymphocytic Leukemia.
Annals of Oncology · 2023
9
cited
Identification of genetic subtypes in follicular lymphoma
Blood Cancer Journal · 2024
6
cited
Pathognomonic and epistatic genetic alterations in B-cell non- Pathognomonic and epistatic genetic alterations in B-cell non-Hodgkin lymphoma [preprint] Hodgkin lymphoma [preprint]
2020
6
cited
Diagnosis, management and follow‐up of follicular lymphoma: a consensus practice statement from the Australasian Lymphoma Alliance
Internal medicine journal (Print) · 2024
5
cited
The Effect of Immune Checkpoint Inhibitors in Patients with Concomitant Advanced Melanoma and Chronic Lymphocytic Leukaemia
2017
5
cited
Show all 64 papers →
Sotabase
Josh Tobin | Researcher Profile | Sotabase | Sotabase